4-EVER : a Trial Investigating the Safety of 4F Endovascular Treatment of Infra-Inguinal Arterial...
Peripheral Vascular DiseaseClaudicationThe objective of this clinical investigation is to evaluate puncture site complication rate as well as the short- and long-term (up to 24 months) outcome of treatment by means of Astron Pulsar / Astron Pulsar-18 stent implantation in symptomatic (Rutherford 2-4) femoro-popliteal arterial stenotic or occlusive lesions, using 4F compatible devices of BIOTRONIK and without the use of a closure device. The hypothesis is that the primary patency at 12 months is non-inferior to the primary patency obtained in the Durability study (72.2%).
BE Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers
Intermittent ClaudicationThe study is designed to evaluate the bioequivalence and the within-subject variability between the test formulation of extended-release tablet of cilostazol (PMR) administered once daily and the reference formulation of immediate- release tablet of cilostazol (Cilostazol) administered twice-daily in normal healthy male and female subjects under fasting conditions.
Choice of Material for Above-Knee Femoro-Popliteal Bypass Prosthetic Graft (PopUp)
Intermittent ClaudicationCritical Limb IschemiaThis trial was designed to challenge the wide held view that polytetrafluoroethylene (PTFE) performs better than Dacron for above knee femoropopliteal bypass.
The MiDAS ENCORE Study
Spinal StenosisLumbar Region1 moreStudy Objective: To compare patient outcomes following treatment with either the MILD procedure or epidural steroid injections (ESIs) in patients with painful lumbar spinal stenosis exhibiting neurogenic claudication and having verified ligamentum flavum hypertrophy as a contributing factor.
PTA vs. Primary Stenting of SFA Using Self-Expandable Nitinol Stents
Peripheral Vascular DiseasesIntermittent Claudication1 moreThe investigators evaluated whether primary implantation of a self-expanding nitinol stent yielded anatomical and clinical benefits superior to those afforded by percutaneous transluminal angioplasty with optional secondary stenting.
Bioequivalency Study of 50 mg Cilostazol Tablets Under Fasting Conditions
Intermittent ClaudicationThe objective of this study was the bioequivalence of a Roxane Laboratories' Cilostazol Tablets, 50 mg, to PLETAL® Tablets, 50 mg (OTSUKA Pharmaceuticals) under fasting conditions using a single-dose, randomized, 2-treatment, 2-period, crossover design.
Trial Comparing Different Medical Devices for Infragenual Dilatation
Diabetic AngiopathiesIntermittent ClaudicationThis study is a comparison of different medical devices for infragenual dilatation.
Clinical Trial to Evaluate the Efficacy and Safety of Sarpogrelate SR in Patients With Chronic Artery...
Arterial Occlusive DiseasesIntermittent ClaudicationThis clinical trial aims to assess the non-inferiority of Sarpogrelate SR 300mg once daily compared to Sarpogrelate 100mg three times daily in patients having intermittent claudication among chronic artery occlusive disease, based on changes in the Ankle-Brachial Index (ABI).
Observational Feasibility Study of Home-based Training With Therabands in PAD-patients
Peripheral Artery DiseaseIntermittent ClaudicationThe study is an observational feasibility study to evaluate the feasibility of a combined aerobic+resistance training program in patients with IC.
Bioequivalence Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy...
Intermittent ClaudicationThe study is designed to evaluate the bioequivalence and the within-subject variability between the test formulation of extended-release tablet of cilostazol (PMR) administered once daily and the reference formulation of immediate-release tablet of cilostazol (Cilostazol) administered twice-daily in normal healthy male and female subjects under fasting conditions.